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Background: We investigated in a cohort study, for the first time using 7-day food 
diaries (7-DFDs), for age-dependent inverse associations with antioxidants, which 
have anti-carcinogenic properties, and development of Barrett’s oesophagus (BO) 
and oesophageal adenocarcinoma (OAC).   
 
Methods: 24, 068 well individuals completed 7-DFDs and donated blood. Vitamins 
C and E, carotenes, zinc and selenium intakes, and plasma vitamin C were 
measured.  Participants were monitored for 15 years for BO and OAC.  Hazard 
ratios (HRs) were estimated for: quintiles of intake and in participants younger and 
>= 65 years at recruitment, the mid-point of BO peak prevalence.  
 
Results: 197 participants developed BO and 74 OAC. There were no significant 
associations between antioxidants and BO or OAC in the whole cohort or if >65 
years at recruitment. In participants <65 years, for BO, there was an inverse trend 
across plasma vitamin C quintiles (trend HR = 0.82; 95% CI = 0.71-0.96, P=0.01), 
OAC for plasma vitamin C (trend HR=0.58; 95% CI=0.37-0.92, P=0.02) and for 
dietary vitamins C & E (trend HR=0.71 95% CI=0.51-0.99, P=0.04 & trend HR=0.70; 
95% CI=0.51-0.96; P=0.03).   
 
Conclusions: Data supports a role for dietary antioxidants prevent BO and OAC, 













The aetiology of both BO and OAC, and the exposures that influence the malignant 
transformation of BO, is not fully understood. The carcinogenic processes may 
involve oxidative stress, whereby electrons are removed from: DNA, cellular 
proteins and membrane lipids (1,2). Dietary antioxidants including vitamins C and 
E, beta-carotene, selenium and zinc may inhibit oxidation and protect against BO 
and OAC. For BO, results from epidemiological studies investigating these dietary 
micronutrients are inconsistent (3–7). Conversely, for OAC observational work 
consistently documents inverse associations with high dietary antioxidant intakes 
(3,6–11). A meta-analysis of 8 case-control studies of OAC reported such 
associations for the highest vs lowest quartiles of vitamin C (OR = 0.49, 95% CI = 
0.39–0.62), beta-carotene (OR = 0.46, 95% CI = 0.36–0.59), and vitamin E (OR = 
0.80, 95% CI = 0.63–1.03) (9). However, all included studies were case-control 
investigations prone to both recall and selection biases. Furthermore, nutritional 
intakes were measured with semi-quantitative food frequency questionnaires 
(FFQs), which are less accurate than seven-day food diaries (7-DFDs). 
We conducted a prospective cohort study to estimate, with more precision than 
previous work by using food diaries, if there were inverse associations between 
dietary antioxidants and the development of BO and OAC in the same population. 
To suggest whether dietary antioxidants influence either the earlier, later or both 
stages of carcinogenesis, we investigated micronutrient intake and the subsequent 
development of OAC differentially above and below the age of 65 years at 
recruitment. This age is the mid-point of the age range 60-69 years which is the 
peak prevalence of BO diagnoses (12) when at least metaplasia, with or without 
dysplasia is present. Demonstrating inverse associations with higher antioxidant 
intakes may support population-based dietary interventions to prevent this highly 
aggressive cancer and justify randomised controlled trials of antioxidants in 
inhibiting the malignant progression of BO to OAC. 
METHODS 
 
The cohort comprised 24,068 individuals, aged 40-79 years, in the European 
Prospective Investigation of Cancer-Norfolk (EPIC-Norfolk) study, recruited 
between 1993 and 1997. At recruitment participants completed questionnaires on: 
demography, habitual diet, and lifestyle including smoking. Participants attended a 
baseline health check, conducted by a nurse, who took non-fasting blood samples 
and anthropometric measurements. The nurse explained the 7-DFD, the first day 
which was a 24-hour recall of previous day’s intake. Participants completed the 
remaining 6 days at home documenting their entire intake. This included: food 
types, portion sizes, brands, cooking methods and recipes in eight separate meal 
and snack times. The 7-DFDs were returned and nutritionists inputted the data into 
a computer program called DINER (Data Into Nutrients for Epidemiological 
Research) (13). Nutritionists matched each diary entry to one of 11,000 food items 
and 55,000 portion sizes within DINER, which best described it. DINER facilitated 
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translation of participant-reported food consumption into structured nutrient 
data. Each 7-DFD had an average of 220 individual food and drink items reported. 
From this process, the daily intakes of vitamins C & E, zinc, selenium and carotenes 
were calculated.  Plasma vitamin C was measured as a marker of bioavailability and 
intake. The cohort was monitored up 30th June 2015 to identify participants who 
developed either incident BO or OAC.  Cases notes were reviewed by clinical 
gastroenterologists, and to be included cases needed both endoscopic and 
histological verification.   
 
In the analysis, micronutrients intakes from 7-DFDs and plasma vitamin C 
concentrations were divided into quintiles. There were 23,624 non-cases from the 
cohort, who had had their 7-DFDs coded. Cox proportional hazards models 
estimated hazard ratios (HRs) for developing BO or OAC separately for quintiles of 
antioxidants and plasma vitamin C. Analyses were adjusted for covariates of 
recruitment age and gender, and in a second model additionally body mass index 
(BMI), smoking, alcohol, energy intake, vitamin supplements and educational level. 
Analyses were repeated for participants younger and older than sixty-five years at 
recruitment, the mean of the reported midpoint of age range of BO (12,14). We 
performed tests for linear trend across quintile categories of intake. 
 
RESULTS 
During follow-up, 197 participants were diagnosed with BO and 74 for OAC, with 
data from 23,624 non-cases available (table 1). Metaplasia was classed as either: 
intestinal 69%, gastric 10%, mosaic 10% and not reported 11%.  In total, 5% of 
participants had dysplasia and 7% subsequently developed OAC. In the 
multivariable analyses of participants in the whole cohort (91% completed all 7 
days of the diary), there were no statistically significant associations between any 
quintile of dietary vitamin C, vitamin E, zinc, selenium or carotenes, and the risk of 
either BO or OAC, and no trends across any quintiles (tables 2 & 3,  data on zinc, 
selenium and carotenes not shown. Similarly, there were no such associations 
when these analyses were repeated for participants older than sixty-five years at 
recruitment. However, in participants younger than 65 years at recruitment who 
developed BO, statistically non-significant inverse associations were observed 
between all quintiles of both food-diary assessed and plasma vitamin C (highest vs 
lowest quintile of dietary vitamin C HR=0.57, 95% CI=0.31-1.04, p=0.07; highest vs 
lowest quintile of plasma vitamin C HR=0.48, 95% CI=0.23-1.01, p=0.06), with a 
significant inverse trend across quintiles for plasma vitamin C and BO risk (trend 
HR = 0.82; 95% CI = 0.71-0.96; p=0.01). There were no associations in this younger 
age group with any of the other dietary antioxidants. For OAC, participants 
recruited younger than 65 years, there were non-significant inverse associations 
for all quintiles of both dietary and plasma vitamin C (highest vs lowest quintile of 
dietary vitamin C HR= 0.36, 95% CI=0.07-1.83, p=0.22; highest vs lowest quintile 
of plasma vitamin C HR=0.30, 95% CI=0.06-1.45, p=0.14), with significant inverse 
trends across quintiles for both dietary vitamin C intake (trend HR=0.71; 95% 
CI=0.51-0.99; p=0.04) and plasma vitamin C (trend HR=0.58; 95% CI=0.37-0.92; 
p=0.02). In this younger age group, there was a significant inverse association 
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across quintiles of vitamin E intake and OAC (trend HR=0.70; 95% CI=0.51-0.96; 




The main findings of this observational study were large inverse associations 
between both dietary and plasma vitamin C, dietary vitamin E and the risk of OAC , 
plus plasma vitamin C and BO, in participants at recruitment aged younger, but not 
older than, 65 years. Some evidence these associations may be protective ones are: 
plausible biological mechanisms for antioxidants preventing BO and OAC, large 
effect sizes, a biological gradient, associations persisting after correcting for 
confounders and temporality of dietary data collection, although to infer causality 
the findings need to be replicated in similar aetiological studies. The reasons for 
the inverse association between vitamins C and E and OAC in participants recruited 
younger than 65 years, the mid-point of the peak prevalence of symptomatically 
diagnosed BO, but not those older than 65 years, are uncertain. The molecular 
mechanisms for OAC involve metaplasia, dysplasia and malignant change. Our 
findings of inverse associations in participants recruited before the peak 
prevalence of BO and then the subsequent development of OAC is consistent with 
the hypothesis that pro-oxidation is involved in the earlier, rather than later 
histological changes in the oesophageal mucosa, which may be attenuated by 
dietary antioxidants. This epidemiological finding would support any laboratory 
mechanistic information showing earlier stages of carcinogenesis involve pro-
oxidation.        
 
The study’s strengths include its prospective design, which ensured that  
antioxidant intakes were assessed prior to symptoms, thereby reducing recall bias. 
A strength was the accuracy of the seven-day food diaries for measuring habitual 
dietary intake which were validated against 16 day weighed records, the gold 
standard for dietary studies. For vitamin C intake, the Spearman correlation 
coefficient for 7-DFDs was 0.70 compared with 0.54 from FFQs (15), hence the 
former attenuate measurement error for diet. Follow-up bias should be minimal, 
as 20 years after EPIC recruitment, 95.6% of the population still have Norfolk post 
codes. In any observational study there is always the possibility of residual 
confounding, namely other dietary variables associated with antioxidant intake, 
which truly influence disease risk. There were relatively small numbers of 
participants in quintiles of antioxidants, although further follow-up will accrue 
more cases to give greater statistical precision. We acknowledge, that inverse 
associations for antioxidants and OAC in the younger age group may be due to 
chance, although full statistical significance was reported for vitamins C and E.   
Only one diary record and plasma sample were recorded at baseline, and some 
individuals’ diets will alter due to illness and seasonal changes. However, as this is 
a prospective cohort design and measurement error is applicable to future cases 
and non-cases, effect sizes will be an under-estimate rather than spurious 
overestimates. Repeated measures of diet over time in a cohort study reported 
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intake remained stable and was unlikely to change between quintile categories 
[16].  
No previous prospective cohort study, whose methodology reduces recall and 
selection biases, has investigated dietary antioxidants and the risk of developing 
both BO and OAC in the same population. Prospective data from our investigation 
suggests the inverse associations with certain antioxidants are more likely to be 
true ones, although confirmation from other cohort studies is required. Such data 
may support randomized controlled trials assessing if these micronutrients 
prevent the transformation of BO.  
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